RENOVE
REduced dose versus full-dose of direct oral anticoagulant after uNprOvoked Venous thromboEmbolism. The RENOVE open-label, randomized, controlled trial
Sponsors:
Brest University Hospital
Brest, France
Status:
- Seeking sites and collaborators
Design
Open-label RCT comparing a reduced dose versus full-dose of direct oral anticoagulant after unprovoked venous thromboembolism
Participating Sites
Lead Network:
INNOVTE
Countries:
FranceLead Investigators
Pr. Francis Couturaud, MD
francis.couturaud@chu-brest.frSubscribe